Regulation of adaptive immunity; the role of interleukin-10

Frontiers in Immunology

Volumn 4, Issue MAY, 2013, Pages

  Ng, T H Sky ^a   Britton, Graham J ^a   Hill, Elaine V ^a   Verhagen, Johan ^a   Burton, Bronwen R ^a   Wraith, David C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Allergy; Autoimmunity; Cytokines; Immune regulation; Immunotherapy; Interleukin 10; Regulatory T cells; T helper cells

Indexed keywords

CALCITRIOL; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 21; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROINSULIN; RECOMBINANT INTERLEUKIN 10; STAT4 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; FEVER; HEADACHE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOTHERAPY; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); POSTOPERATIVE INFLAMMATION; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL; THYMUS; TRANSCRIPTION REGULATION;

EID: 84883697510     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00129     Document Type: Review

References (179)

1. Abrahamsohn, I. A., and Coffman, R. L. (1996). Trypanosoma cruzi:IL-10, TNF, IFN-γ, and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 84, 231-244. doi:10.1006/expr.1996.0109
2. Adris, S., Klein, S., Jasnis, M., Chuluyan, E., Ledda, M., Bravo, A., et al. (1999). IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response. Gene Ther. 6, 1705-1712. doi:10.1038/sj.gt.3301012
3. Akbari, O., DeKruyff, R. H., and Umetsu, D. T. (2001). Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2, 725-731. doi:10.1038/90667
4. Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., et al. (2004). Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199, 1567-1575. doi:10.1084/jem.20032058
5. Allan, D. S. J., Colonna, M., Lanier, L. L., Churakova, T. D., Abrams, J. S., Ellis, S. A., et al. (1999). Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 189, 1149-1156. doi:10.1084/jem.189.7.1149
6. 4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204, 285-297. doi:10.1084/jem.20061886
7. Apetoh, L., Quintana, F. J., Pot, C., Joller, N., Xiao, S., Kumar, D., et al. (2010). The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854-861. doi:10.1038/ni.1912
8. 46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116, 3252-3257. doi:10.1172/jci29251
9. Awasthi, A., Carrier, Y., Peron, J. P., Bettelli, E., Kamanaka, M., Flavell, R. A., et al. (2007). A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380-1389. doi:10.1038/ni1541
10. Bai, X. F., Zhu, J., Zhang, G. X., Kaponides, G., Höjeberg, B., van der Meide, P. H., et al. (1997). IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses. Clin. Immunol. Immunopathol. 83, 117-126. doi:10.1006/clin.1997.4331
11. 4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Cell. Immunol. 170, 41-53. doi:10.1006/cimm.1996.0132
12. 4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195, 603-616. doi:10.1084/jem.20011629
13. Battaglia, M., Stabilini, A., Draghici, E., Gregori, S., Mocchetti, C., Bonifacio, E., et al. (2006). Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55, 40-49. doi:10.2337/diabetes.55.01.06.db05-0613
14. Beebe, A. M., Cua, D. J., and de Waal Malefyt, R. (2002). The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev. 13, 403-412. doi:10.1016/S1359-6101(02)00025-4
15. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., et al. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238. doi:10.1038/nature04753
16. Bettelli, E., Prabhu Das, M., Howard, E. D., Weiner, H. L., Sobel, R. A., and Kuchroo, V. K. (1998). IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161, 3299-3306.
17. Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., et al. (2000). Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 6, 1167-1175. doi:10.1038/80516
18. Bohlen, H., Kessler, M., Sextro, M., Diehl, V., and Tesch, H. (2000). Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease. Ann. Hematol. 79, 110-113. doi:10.1007/s002770050564
19. Borish, L. (1998). IL-10: Evolving concepts. J. Allergy Clin. Immunol. 101, 293-297. doi:10.1016/S0091-6749(98)70238-6
20. Boussiotis, V. A., Tsai, E. Y., Yunis, E. J., Thim, S., Delgado, J. C., Dascher, C. C., et al. (2000). IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105, 1317-1325. doi:10.1172/JCI9918
21. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankensteini, T., et al. (1996). Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343-346. doi:10.1038/379343a0
22. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., et al. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73. doi:10.1038/83784
23. Burkhart, C., Liu, G. Y., Anderton, S. M., Metzler, B., and Wraith, D. C. (1999). Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int. Immunol. 11, 1625-1634. doi:10.1093/intimm/11.10.1625
24. Cai, G., Kastelein, R. A., and Hunter, C. A. (1999). IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur. J. Immunol. 29, 2658-2665. doi:10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658<3.3.CO;2-7
25. Cannella, B., Gao, Y. L., Brosnan, C., and Raine, C. S. (1996). IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45, 735-746. doi:10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-V
26. 46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11, 862-871. doi:10.1038/ni.1917
27. Cedeno-Laurent, F., Opperman, M., Barthel, S. R., Kuchroo, V. K., and Dimitroff, C. J. (2012). Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J. Immunol. 188, 3127-3137. doi:10.4049/jimmunol.1103433
28. Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., et al. (2002). Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3, 237-243. doi:10.1038/ni760
29. Chang, H. D., Helbig, C., Tykocinski, L., Kreher, S., Koeck, J., Niesner, U., et al. (2007). Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. Eur. J. Immunol. 37, 807-817. doi:10.1002/eji.200636385
30. Chau, G. Y., Wu, C. W., Lui, W. Y., Chang, T. J., Kao, H. L., Wu, L. H., et al. (2000). Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann. Surg. 231, 552-558. doi:10.1097/00000658-200004000-00015
31. Chaudhry, A., and Rudensky, A. Y. (2013). Control of inflammation by integration of environmental cues by regulatory T cells. J. Clin. Invest. 123, 939-944. doi:10.1172/JCI57175
32. Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J. M., et al. (2011). Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566-578. doi:10.1016/j.immuni.2011.03.018
33. Colombel, J.-F., Rutgeerts, P., Malchow, H., Jacyna, M., Nielsen, O. H., Rask-Madsen, J., et al. (2001). Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 49, 42-46. doi:10.1136/gut.49.1.42
34. Crawley, E., Kay, R., Sillibourne, J., Patel, P., Hutchinson, I., and Woo, P. (1999). Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 42, 1101-1108. doi:10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y
35. Cua, D. J., Groux, H., Hinton, D. R., Stohlman, S. A., and Coffman, R. L. (1999). Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189, 1005-1010. doi:10.1084/jem.189.6.1005
36. Cua, D. J., Hutchins, B., LaFace, D. M., Stohlman, S. A., and Coffman, R. L. (2001). Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166, 602-608.
37. Curotto de Lafaille, M. A., Lino, A. C., Kutchukhidze, N., and Lafaille, J. J. (2004). CD25- T cells generate CD25+Foxp3+ regulatory t cells by peripheral expansion. J. Immunol. 173, 7259-7268.
38. Dai, W. J., Köhler, G., and Brombacher, F. (1997). Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158, 2259-2267.
39. Deckert, M., Soltek, S., Geginat, G., Lutjen, S., Montesinos-Rongen, M., Hof, H., et al. (2001). Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect. Immun. 69, 4561-4571. doi:10.1128/IAI.69.7.4561-4571.2001
40. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., and Anderton, S. M. (2002). B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944-950. doi:10.1038/ni833
41. Fiorentino, D. F., Bond, M. W., and Mosmann, T. R. (1989). Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095. doi:10.1084/jem.170.6.2081
42. 4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336. doi:10.1038/ni904
43. 4+CD25+ T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 111, 1255-1261. doi:10.1067/mai.2003.1570
44. Gabryšová, L., Nicolson, K. S., Streeter, H. B., Verhagen, J., Sabatos-Peyton, C. A., Morgan, D. J., et al. (2009). Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J. Exp. Med. 206, 1755-1767. doi:10.1084/jem.20082118
45. Gabryšová, L., and Wraith, D. C. (2010). Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells. Eur. J. Immunol. 40, 1386-1395. doi:10.1002/eji.200940151
46. 49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. doi:10.1038/nm.3179
47. Gambineri, E., Torgerson, T. R., and Ochs, H. D. (2003). Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15, 430-435. doi:10.1097/00002281-200307000-00010
48. Garcia-Hernandez, M. L., Hernandez-Pando, R., Gariglio, P., and Berumen, J. (2002). Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation. Immunology 105, 231-243. doi:10.1046/j.1365-2567.2002.01363.x
49. Gazzinelli, R. T., Wysocka, M., Hayashi, S., Denkers, E. Y., Hieny, S., Caspar, P., et al. (1994). Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153, 2533-2543.
50. 4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157, 798-805.
51. Gerard, C. M., Bruyns, C., Delvaux, A., Baudson, N., Dargent, J. L., Goldman, M., et al. (1996). Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells. Hum. Gene Ther. 7, 23-31. doi:10.1089/hum.1996.7.1-23
52. 4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 92, 224-234. doi:10.1006/clim.1999.4752
53. Gibson, A. W., Edberg, J. C., Wu, J., Westendorp, R. G. J., Huizinga, T. W. J., and Kimberly, R. P. (2001). Novel Single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 166, 3915-3922.
54. Giovarelli, M., Musiani, P., Modesti, A., Dellabona, P., Casorati, G., Allione, A., et al. (1995). Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol. 155, 3112-3123.
55. Gonzalez-Aragoneses, F., Moreno-Mata, N., Cebollero-Presmanes, M., Garcia-Yuste, M., Canizares-Carretero, M. A., Molins-Lopez-Rodo, L., et al. (2007). Prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung. Cancer 110, 1776-1781. doi:10.1002/cncr.22985
56. Gottschalk, R. A., Corse, E., and Allison, J. P. (2012). Expression of helios in peripherally induced Foxp3+ regulatory T cells. J. Immunol. 188, 976-980. doi:10.4049/jimmunol.1102964
57. Gregori, S., Tomasoni, D., Pacciani, V., Scirpoli, M., Battaglia, M., Magnani, C. F., et al. (2010). Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116, 935-944. doi:10.1182/blood-2009-07-234872
58. Groux, H., Bigler, M., de Vries, J. E., and Roncarolo, M. G. (1998). Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J. Immunol. 160, 3188-3193.
59. Groux, H., Cottrez, F., Rouleau, M., Mauze, S., Antonenko, S., Hurst, S., et al. (1999). A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162, 1723-1729.
60. 4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742. doi:10.1038/39614
61. Grünig, G., Corry, D. B., Leach, M. W., Seymour, B. W. P., Kurup, V. P., and Rennick, D. M. (1997). Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary Aspergillosis. J. Exp. Med. 185, 1089-1100. doi:10.1084/jem.185.6.1089
62. Hajeer, A. H., Lazarus, M., Turner, D., Mageed, R. A., Vencovsky, J., Sinnott, P., et al. (1998). IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand. J. Rheumatol. 27, 142-145. doi:10.1080/030097498441029
63. Halak, B. K., Maguire, H. C. Jr., and Lattime, E. C. (1999). Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site. Cancer Res. 59, 911-917.
64. Hashimoto, T., Akiyama, K., Kobayashi, N., and Mori, A. (2005). Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int. Arch. Allergy Immunol. 137(Suppl. 1), 51-54. doi:10.1159/000085432
65. Hata, H., Sakaguchi, N., Yoshitomi, H., Iwakura, Y., Sekikawa, K., Azuma, Y., et al. (2004). Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J. Clin. Invest. 114, 582-588. doi:10.1172/JCI21795
66. Hawrylowicz, C., Richards, D., Loke, T. K., Corrigan, C., and Lee, T. A. (2002). defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. J. Allergy Clin. Immunol. 109, 369-370. doi:10.1067/mai.2002.121455
67. Himmel, M. E., MacDonald, K. G., Garcia, R. V., Steiner, T. S., and Levings, M. K. (2013). Helios+ and helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J. Immunol. 190, 2001-2008. doi:10.4049/jimmunol.1201379
68. 4+CD25highFOXP3+ cells in type 1 diabetic patients. Clin. Immunol. 138, 117-126. doi:10.1016/j.clim.2010.10.004
69. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061. doi:10.1126/science.1079490
70. 4+ T cells in an interleukin-10-dependent manner. Immunity 34, 554-565. doi:10.1016/j.immuni.2011.01.020
71. Hunter, C. A., Ellis-Neyes, L. A., Slifer, T., Kanaly, S., Grunig, G., Fort, M., et al. (1997). IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158, 3311-3316.
72. Ilarregui, J. M., Croci, D. O., Bianco, G. A., Toscano, M. A., Salatino, M., Vermeulen, M. E., et al. (2009). Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 10, 981-991. doi:10.1038/ni.1772
73. Im, S. H., Hueber, A., Monticelli, S., Kang, K. H., and Rao, A. (2004). Chromatin-level regulation of the IL10 gene in T cells. J. Biol. Chem. 279, 46818-46825. doi:10.1074/jbc.M401722200
74. Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., et al. (2006). The orphan nuclear receptor ROR3t directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133. doi:10.1016/j.cell.2006.07.035
75. Jacobs, Z., and Ciaccio, C. E. (2010). Periodic fever syndromes. Curr. Allergy Asthma Rep. 10, 398-404. doi:10.1007/s11882-010-0141-z
76. 46 transgenic mice. J. Immunol. 175, 433-440.
77. John, M., Lim, S. A. M., Seybold, J., Jose, P., Robichaud, A., O'Connor, B., et al. (1998). Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1 a, granulocyte-macrophage colony-stimulating factor, and interferon-? release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med. 157, 256-262. doi:10.1164/ajrccm.157.1.9703079
78. Josefowicz, S. Z., Niec, R. E., Kim, H. Y., Treuting, P., Chinen, T., Zheng, Y., et al. (2012). Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482, 395-399. doi:10.1038/nature10772
79. Jutel, M., Akdis, M., Budak, F., Aebischer-Casaulta, C., Wrzyszcz, M., Blaser, K., et al. (2003). IL-10 and TGF-ß cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33, 1205-1214. doi:10.1002/eji.200322919
80. Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., et al. (2000). Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The altered peptide ligand in relapsing MS study group. Nat. Med. 6, 1176-1182. doi:10.1038/80525
81. Karagiannidis, C., Akdis, M., Holopainen, P., Woolley, N. J., Hense, G., Rückert, B., et al. (2004). Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114, 1425-1433. doi:10.1016/j.jaci.2004.07.014
82. Kemp, K., Kemp, M., Kharazmi, A., Ismail, A., Kurtzhals, J. A., Hviid, L., et al. (1999). Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin. Exp. Immunol. 116, 500-504. doi:10.1046/j.1365-2249.1999.00918.x
83. 46 induces a T-regulatory cell 1 phenotype. Nature 421, 388-392. doi:10.1038/nature01315
84. Kim, J., Modlin, R. L., Moy, R. L., Dubinett, S. M., McHugh, T., Nickoloff, B. J., et al. (1995). IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J. Immunol. 155, 2240-2247.
85. Kim, J. I., Ho, I. C., Grusby, M. J., and Glimcher, L. H. (1999). The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 10, 745-751. doi:10.1016/S1074-7613(00)80073-4
86. Korenaga, M., Hitoshi, Y., Yamaguchi, N., Sato, Y., Takatsu, K., and Tada, I. (1991). The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice. Immunology 72, 502-507.
87. Kornete, M., Sgouroudis, E., and Piccirillo, C. A. (2012). ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J. Immunol. 188, 1064-1074. doi:10.4049/jimmunol.1101303
88. Kubo, M., and Motomura, Y. (2012). Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells. Front. Immunol. 3:275 doi:10.3389/fimmu.2012.00275
89. Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., and Müller, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274. doi:10.1016/0092-8674(93)80068-P
90. Lauw, F. N., Pajkrt, D., Hack, C. E., Kurimoto, M., van Deventer, S. J., and van der Poll, T. (2000). Proinflammatory effects of IL-10 during human endotoxemia. J. Immunol. 165, 2783-2789.
91. Lavelle, E. C., Jarnicki, A., McNeela, E., Armstrong, M. E., Higgins, S. C., Leavy, O., et al. (2004). Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J. Leukoc. Biol. 75, 756-763. doi:10.1189/jlb.1103534
92. Lavelle, E. C., McNeela, E., Armstrong, M. E., Leavy, O., Higgins, S. C., and Mills, K. H. G. (2003). Cholera toxin promotes the induction of regulatory T cells specific for Bystander antigens by modulating dendritic cell activation. J. Immunol. 171, 2384-2392.
93. Lech-Maranda, E., Baseggio, L., Bienvenu, J., Charlot, C., Berger, F., Rigal, D., et al. (2004). Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 103, 3529-3534. doi:10.1182/blood-2003-06-1850
94. 4+ T cells. Proc. Natl. Acad. Sci. U.S.A. 101, 7064-7069. doi:10.1073/pnas.0401922101
95. Leon, L. R., Kozak, W., and Kluger, M. J. (1998). Role of IL-10 in inflammation. Studies using cytokine knockout mice. Ann. N. Y. Acad. Sci. 856, 69-75. doi:10.1111/j.1749-6632.1998.tb08314.x
96. Lim, S., Crawley, E., Woo, P., and Barnes, P. J. (1998). Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 352, 113. doi:10.1016/S0140-6736(98)85018-6
97. Linden, A., Hoshino, H., and Laan, M. (2000). Airway neutrophils and interleukin-17. Eur. Respir. J. 15, 973-977. doi:10.1034/j.1399-3003.2000.15e28.x
98. Linke, A., Kuhn, R., Muller, W., Honarvar, N., Li, C., and Langhorne, J. (1996). Plasmodium chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp. Parasitol. 84, 253-263. doi:10.1006/expr.1996.0111
99. 4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 100, 15047-15052. doi:10.1073/pnas.2536517100
100. Ludvigsson, J., Krisky, D., Casas, R., Battelino, T., Castaño, L., Greening, J., et al. (2012). GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N. Engl. J. Med. 366, 433-442. doi:10.1056/NEJMoa1107096
101. Male, V., Nisoli, I., Gascoyne, D. M., and Brady, H. J. M. (2012). E4BP4: an unexpected player in the immune response. Trends Immunol. 33, 98-102. doi:10.1016/j.it.2011.10.002
102. Maloy, K. J., and Powrie, F. (2001). Regulatory T cells in the control of immune pathology. Nat. Immunol. 2, 816-822. doi:10.1038/ni0901-816
103. Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., et al. (2003). High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11, 245-258. doi:10.1016/S0966-3274(03)00058-3
104. Mathisen, P. M., Yu, M., Johnson, J. M., Drazba, J. A., and Tuohy, V. K. (1997). Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186, 159-164. doi:10.1084/jem.186.1.159
105. Matusevicius, D., Kivisakk, P., He, B., Kostulas, N., Ozenci, V., Fredrikson, S., et al. (1999). Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5, 101-104. doi:10.1191/135245899678847275
106. Mauri, C., and Bosma, A. (2012). Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221-241. doi:10.1146/annurev-immunol-020711-074934
107. Maynard, C. L., Harrington, L. E., Janowski, K. M., Oliver, J. R., Zindl, C. L., Rudensky, A. Y., et al. (2007). Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 8, 931-941. doi:10.1038/ni1504
108. Maynard, C. L., and Weaver, C. T. (2008). Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol. Rev. 226, 219-233. doi:10.1111/j.1600-065X.2008.00711.x
109. McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., et al. (2007). TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390-1397. doi:10.1038/ni1539
110. McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W. M., et al. (2009). The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10, 314-324. doi:10.1038/ni.1698
111. Meiler, F., Zumkehr, J., Klunker, S., Rückert, B., Akdis, C. A., and Akdis, M. (2008). In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 205, 2887-2898. doi:10.1084/jem.20080193
112. Metzler, B., and Wraith, D. C. (1993). Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5, 1159-1165. doi:10.1093/intimm/5.9.1159
113. Micallef, M. J., Tanimoto, T., Torigoe, K., Nishida, Y., Kohno, K., Ikegami, H., et al. (1999). Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity. Cancer Immunol. Immunother. 48, 109-117. doi:10.1007/s002620050554
114. Miller, S. D., Turley, D. M., and Podojil, J. R. (2007). Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat. Rev. Immunol. 7, 665-677. doi:10.1038/nri2153
115. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., and O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765. doi:10.1146/annurev.immunol.19.1.683
116. Morinobu, A., Gadina, M., Strober, W., Visconti, R., Fornace, A., Montagna, C., et al. (2002). STAT4 serine phosphorylation is critical for IL-12-induced IFN-γ production but not for cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 99, 12281-12286. doi:10.1073/pnas.182618999
117. 4+ T cells. Nat. Immunol. 12, 450-459. doi:10.1038/ni.2020
118. Muller, S., Monneaux, F., Schall, N., Rashkov, R. K., Oparanov, B. A., Wiesel, P., et al. (2008). Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial. Arthritis Rheum. 58, 3873-3883. doi:10.1002/art.24027
119. Nagelkerken, L., Blauw, B., and Tielemans, M. (1997). IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int. Immunol. 9, 1243-1251.
120. Nemunaitis, J., Fong, T., Shabe, P., Martineau, D., and Ando, D. (2001). Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma. Cancer Invest. 19, 239-247. doi:10.1081/CNV-100102550
121. 4 T cells. J. Immunol. 177, 1062-1069.
122. Oakley, O. R., Garvy, B. A., Humphreys, S., Qureshi, M. H., and Pomeroy, C. (2008). Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus. Clin. Exp. Immunol. 151, 155-164. doi:10.1111/j.1365-2249.2007.03533.x
123. O'Garra, A., Barrat, F. J., Castro, A. G., Vicari, A., and Hawrylowicz, C. (2008). Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 223, 114-131. doi:10.1111/j.1600-065X.2008.00635.x
124. O'Garra, A., and Vieira, P. (2004). Regulatory T cells and mechanisms of immune system control. Nat. Med. 10, 801-805. doi:10.1038/nm0804-801
125. O'Garra, A., and Vieira, P. (2007). T(H)1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 7, 425-428. doi:10.1038/nri2097
126. Ouyang, W., Löhning, M., Gao, Z., Assenmacher, M., Ranganath, S., Radbruch, A., et al. (2000). Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12, 27-37. doi:10.1016/S1074-7613(00)80156-9
127. 4+CD25+ T cells. Immunity 25, 249-259. doi:10.1016/j.immuni.2006.05.016
128. Pot, C., Jin, H., Awasthi, A., Liu, S. M., Lai, C.-Y., Madan, R., et al. (2009). Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183, 797-801. doi:10.4049/jimmunol.0901233
129. Prakken, B. J., Samodal, R., Le, T. D., Giannoni, F., Yung, G. P., Scavulli, J., et al. (2004). Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 101, 4228-4233. doi:10.1073/pnas.0400061101
130. Redford, P. S., Murray, P. J., and O'Garra, A. (2011). The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4, 261-270. doi:10.1038/mi.2011.7
131. Reich, K., Garbe, C., Blaschke, V., Maurer, C., Middel, P., Westphal, G., et al. (2001). Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin-8//CXCR2 pathway and normalization of keratinocyte maturation. J. Invest. Dermatol. 116, 319-329.
132. Richards, D. F., Fernandez, M., Caulfield, J., and Hawrylowicz, C. M. (2000). Glucocorticoids drive human CD8+ T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur. J. Immunol. 30, 2344-2354. doi:10.1002/1521-4141(2000)30:8<2344::AID-IMMU2344>3.0.CO;2-7
133. Rizzo, L. V., Xu, H., Chan, C. C., Wiggert, B., and Caspi, R. R. (1998). IL-10 has a protective role in experimental autoimmune uveoretinitis. Int. Immunol. 10, 807-814. doi:10.1093/intimm/10.6.807
134. Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., et al. (1992). Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326, 298-304. doi:10.1056/NEJM199201303260504
135. Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., et al. (1997). Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185, 825-832. doi:10.1084/jem.185.5.825
136. Romagnani, S. (1994). Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12, 227-257. doi:10.1146/annurev.iy.12.040194.001303
137. Romagnani, S. (1996). TH1 and TH2 in human diseases. Clin. Immunol. Immunopathol. 80, 225-235. doi:10.1006/clin.1996.0118
138. Roncarolo, M. G., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., and Levings, M. K. (2006). Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50. doi:10.1111/j.0105-2896.2006.00420.x
139. Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., et al. (2008). Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558. doi:10.1016/j.immuni.2008.02.017
140. Sabatos-Peyton, C. A., Verhagen, J., and Wraith, D. C. (2010). Antigen-specific immunotherapy of autoimmune and allergic diseases. Curr. Opin. Immunol. 22, 609-615. doi:10.1016/j.coi.2010.08.006
141. Samstein, R. M., Josefowicz, S. Z., Arvey, A., Treuting, P. M., and Rudensky, A. Y. (2012). Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150, 29-38. doi:10.1016/j.cell.2012.05.031
142. Saraiva, M., Christensen, J. R., Veldhoen, M., Murphy, T. L., Murphy, K. M., and O'Garra, A. (2009). Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31, 209-219. doi:10.1016/j.immuni.2009.05.012
143. Saraiva, M., and O'Garra, A. (2010). The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181. doi:10.1038/nri2711
144. Schall, N., Page, N., Macri, C., Chaloin, O., Briand, J.-P., and Muller, S. (2012). Peptide-based approaches to treat lupus and other autoimmune diseases. J. Autoimmun. 39, 143-153. doi:10.1016/j.jaut.2012.05.016
145. Schopf, L. R., Hoffmann, K. F., Cheever, A. W., Urban, J. F., and Wynn, T. A. (2002). IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J. Immunol. 168, 2383-2392.
146. Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., et al. (1998). Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224-5231.
147. Shoda, L. K., Young, D. L., Ramanujan, S., Whiting, C. C., Atkinson, M. A., Bluestone, J. A., et al. (2005). A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23, 115-126. doi:10.1016/j.immuni.2005.08.002
148. 4+ T cells. J. Immunol. 176, 3470-3479.
149. Sieling, P. A., Abrams, J. S., Yamamura, M., Salgame, P., Bloom, B. R., Rea, T. H., et al. (1993). Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J. Immunol. 150, 5501-5510.
150. Silva, J. S., Morrissey, P. J., Grabstein, K. H., Mohler, K. M., Anderson, D., and Reed, S. G. (1992). Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175, 169-174. doi:10.1084/jem.175.1.169
151. Slavin, A. J., Maron, R., and Weiner, H. L. (2001). Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int. Immunol. 13, 825-833. doi:10.1093/intimm/13.6.825
152. Steinman, L. A. (2007). brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13, 139-145. doi:10.1038/nm0307-385a
153. Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., et al. (2007). Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363-1371. doi:10.1038/ni1537
154. Sun, J., Madan, R., Karp, C. L., and Braciale, T. J. (2009). Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15, 277-284. doi:10.1038/nm.1929
155. 4(+)CD25(+) T cells. J. Autoimmun. 16, 115-123. doi:10.1006/jaut.2000.0473
156. Taylor, A., Akdis, M., Joss, A., Akkoç, T., Wenig, R., Colonna, M., et al. (2007). IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J. Allergy Clin. Immunol. 120, 76-83. doi:10.1016/j.jaci.2007.04.004
157. Taylor, A., Verhagen, J., Akkoc, T., Wenig, R., Flory, E., Blaser, K., et al. (2009). IL-10 suppresses CD2-mediated T cell activation via SHP-1. Mol. Immunol. 46, 622-629. doi:10.1016/j.molimm.2008.07.031
158. Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., et al. (2010). Expression of helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433-3441. doi:10.4049/jimmunol.0904028
159. Thrower, S. L., James, L., Hall, W., Green, K. M., Arif, S., Allen, J. S., et al. (2009). Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study. Clin. Exp. Immunol. 155, 156-165. doi:10.1111/j.1365-2249.2008.03814.x
160. Tian, J., Atkinson, M. A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmann, P. V., et al. (1996). Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183, 1561-1567. doi:10.1084/jem.183.4.1561
161. Tilg, H., van Montfrans, C., van den Ende, A., Kaser, A., van Deventer, S. J., Schreiber, S., et al. (2002). Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 50, 191-195. doi:10.1136/gut.50.2.191
162. Trinchieri, G. (2007). Interleukin-10 production by effector T cells: Th1 cells show self control. J. Exp. Med. 204, 239-243. doi:10.1084/jem.20070104
163. 4+CD25+ T cells during cure of colitis. J. Immunol. 177, 5852-5860.
164. 4+ cells in human allergic diseases. J. Allergy Clin. Immunol. 100, 1-6. doi:10.1016/S0091-6749(97)70186-6
165. Umetsu, D. T., and DeKruyff, R. H. (1999). Interleukin-10: The missing link in asthma regulation? Am. J. Respir. Cell Mol. Biol. 21, 562-563. doi:10.1165/ajrcmb.21.5.f171
166. Urban, J. F. Jr., Katona, I. M., Paul, W. E., and Finkelman, F. D. (1991). Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc. Natl. Acad. Sci. U.S.A. 88, 5513-5517. doi:10.1073/pnas.88.13.5513
167. Van Boxel-Dezaire, A. H. H., Hoff, S. C. J., Van Oosten, B. W., Verweij, C. L., Dräger, A. M., Adèr, H. J., and Etalname, A. (1999). Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 45, 695-703. doi:10.1002/1531-8249(199906)45:6<695::AID-ANA3>3.0.CO;2-R
168. Verhagen, J., and Wraith, D. C. (2010). Comment on "expression of helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells". J. Immunol. 185, 7129. doi:10.4049/jimmunol.1090105
169. Vissers, J. L., van Esch, B. C., Hofman, G. A., Kapsenberg, M. L., Weller, F. R., and van Oosterhout, A. J. (2004). Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model. J. Allergy Clin. Immunol. 113, 1204-1210. doi:10.1016/j.jaci.2004.02.041
170. Warren, K. G., Catz, I., Ferenczi, L. Z., and Krantz, M. J. (2006). Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment. Eur. J. Neurol. 13, 887-895. doi:10.1111/j.1468-1331.2006.01533.x
171. Weiss, J. M., Bilate, A. M., Gobert, M., Ding, Y., Curotto de Lafaille, M. A., Parkhurst, C. N., et al. (2012). Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209, 1723-1742. doi:10.1084/jem.20120914
172. Wong, C. K., Ho, C. Y., Li, E. K., and Lam, C. W. (2000). Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9, 589-593. doi:10.1191/096120300678828703
173. Xu, J., Yang, Y., Qiu, G., Lal, G., Wu, Z., Levy, D. E., et al. (2009). c-Maf regulates IL-10 expression during Th17 polarization. J. Immunol. 182, 6226-6236. doi:10.4049/jimmunol.0900123
174. Xystrakis, E., Kusumakar, S., Boswell, S., Peek, E., and Urry, Z. (2006). Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 116, 146-155. doi:10.1172/jci217
175. Yadav, M., Louvet, C., Davini, D., Gardner, J. M., Martinez-Llordella, M., Bailey-Bucktrout, S., et al. (2012). Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713-1722. doi:10.1084/jem.20120822
176. 4 and CD8 T-cell responses. Cancer Res. 63, 2150-2157.
177. 46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 167, 6780-6785.
178. Zheng, L. M., Ojcius, D. M., Garaud, F., Roth, C., Maxwell, E., Li, Z., et al. (1996). Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J. Exp. Med. 184, 579-584. doi:10.1084/jem.184.2.579
179. Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., et al. (2012). Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484, 514-518. doi:10.1038/nature10957